DR. JOHN J ZHANG, MD
Medical Practice in New York, NY
License number
New York 218321
Category
Medical Practice
Type
Specialist
Address
Address
4 Columbus Circle Suite FLOOR 4TH, New York, NY 10019
Phone
(212) 517-7676
(212) 489-6294 (Fax)
(212) 489-6294 (Fax)
Personal information
See more information about JOHN J ZHANG at radaris.comName
Address
Phone
4922 97Th St, Corona, NY 11368
360 E 72Nd St APT B306, New York, NY 10021
83 Park Ter W APT 4C, New York, NY 10034
601 Delafield Ave, Staten Island, NY 10310
6 Hancock Ct, S Setauket, NY 11720
Organization information
See more information about JOHN J ZHANG at bizstanding.comNew Hope Fertility Center - John J Zhang MD
784 Park Ave, New York, NY 10021
Categories:
Urology Physicians & Surgeons
Phone:
(212) 517-7676 (Phone)
Professional information
See more information about JOHN J ZHANG at trustoria.com
Staff Process Development Engineer At Stmicroelectronics/Ibm Isda
Staff Process Development Engineer At Stmicroelectronics/Ibm Isda
Position:
Staff Process Development Engineer at STMicroelectronics, Staff Process Development Engineer at ST Microelectronics
Location:
Greater New York City Area
Industry:
Semiconductors
Work:
STMicroelectronics
since Dec 1999
-
Staff Process Development Engineer
ST Microelectronics
since 1999
-
Staff Process Development Engineer
Education:
The University of Texas at Arlington 1997 - 2000
Ph. D., Physical Chemistry University of Science and Technology of China 1987 - 1992
Ph. D., Chemical Physics Xiamen University 1981 - 1985
BS, Semiconductor
Ph. D., Physical Chemistry University of Science and Technology of China 1987 - 1992
Ph. D., Chemical Physics Xiamen University 1981 - 1985
BS, Semiconductor
Graduate Student At Zicklin School Of Business
Graduate Student At Zicklin School Of Business
Position:
Junior Software Developer at Redstage
Location:
Greater New York City Area
Industry:
Accounting
Work:
Redstage
since Jun 2012
-
Junior Software Developer
AvePoint, Inc
Apr 2010 - Feb 2011
-
Accounting Assistant
Yellow Brick Capital Advisors, LLC
Jun 2008 - Oct 2009
-
Junior Analyst
Navigator Capital Partners
Jan 2007 - Nov 2007
-
Administrative Assistant
Education:
City University of New York-Baruch College - Zicklin School of Business 2010 - 2012
MS, Accountancy City University of New York-Baruch College - Zicklin School of Business 2006 - 2010
BA, Mathematics with Concentration in Finance Bronx High School of Science 2002 - 2006
MS, Accountancy City University of New York-Baruch College - Zicklin School of Business 2006 - 2010
BA, Mathematics with Concentration in Finance Bronx High School of Science 2002 - 2006
Tax Manager At Sony
Tax Manager At Sony
Position:
Tax Manager at SONY
Location:
Greater New York City Area
Industry:
Accounting
Work:
SONY
since Jun 2006
-
Tax Manager
Food &Amp; Beverages Professional
Food &Amp; Beverages Professional
Location:
Greater New York City Area
Industry:
Food & Beverages
Education:
State University of New York College at Plattsburgh 2000 - 2004
Quantitative Analyst At Mzi
Quantitative Analyst At Mzi
Position:
Quantitative Analyst at MZI
Location:
Greater New York City Area
Industry:
Market Research
Work:
MZI
-
Quantitative Analyst
Manager At Speedier Logistics
Manager At Speedier Logistics
Position:
Manager at Speedier Logistics
Location:
Greater New York City Area
Industry:
Transportation/Trucking/Railroad
Work:
Speedier Logistics
-
Manager
Director At T.e. Financial Consultants Ltd.
Director At T.e. Financial Consultants Ltd.
Position:
Director at T.E. Financial Consultants Ltd.
Location:
Greater New York City Area
Industry:
Accounting
Work:
T.E. Financial Consultants Ltd.
-
Director
Officer At 1Zhang.net Inc.
Officer At 1Zhang.net Inc.
Position:
Officer at 1zhang.net Inc.
Location:
Greater New York City Area
Industry:
Information Technology and Services
Work:
1zhang.net Inc.
-
Officer
Compositions And Methods For Treating Obesity, Obesity Related Disorders And For Inhibiting The Infectivity Of Human Immunodeficiency Virus
Compositions And Methods For Treating Obesity, Obesity Related Disorders And For Inhibiting The Infectivity Of Human Immunodeficiency Virus
US Patent:
2009006, Mar 5, 2009
Filed:
Jul 9, 2007
Appl. No.:
11/827135
Inventors:
Sylvia Lee-Huang - New York NY, US
Paul L. Huang - Boston MA, US
Philip Lin Huang - Maple Glen PA, US
Dawei Zhang - Elmhurst NY, US
John Z.H. Zhang - New York NY, US
Young Tae Chang - New York NY, US
Jae Wook Lee - San Diego CA, US
Ju Bao - Brooklyn NY, US
Yongtao Sun - Chaanxi Province, CN
Paul L. Huang - Boston MA, US
Philip Lin Huang - Maple Glen PA, US
Dawei Zhang - Elmhurst NY, US
John Z.H. Zhang - New York NY, US
Young Tae Chang - New York NY, US
Jae Wook Lee - San Diego CA, US
Ju Bao - Brooklyn NY, US
Yongtao Sun - Chaanxi Province, CN
International Classification:
A61K 36/00, A61K 31/351, A61K 31/70, A61K 38/28, A61K 31/4439, A61K 31/435, A61K 31/366, A61K 31/7036, A61P 3/00, A61P 31/12, A61K 31/175, A61K 31/445, A61K 31/404, A61K 31/40, A61K 31/427, A61K 31/155, A61K 31/05
US Classification:
424774, 514460, 514734, 514 27, 514636, 514 4, 514369, 514342, 514423, 514277, 514419, 514635, 514634, 514331, 514 42, 514592
Abstract:
The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPARγ2, LPL and αP2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual. The invention further provides for screening for novel oleuropein analogues.